Fuji Chemical Industries Co., Ltd.

DUBLIN, March 27, 2023 /PRNewswire/ -- The "Microalgae: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Microalgae Market to Reach $1.6 Billion by 2030 The global market for Microalgae estimated at US$1 Billion in the year 2022, is projected to reach a revised size of US$1.6 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2022-2030. Spirulina, one of the segments analyzed in the report, is projected to record a 6.5% CAGR and reach US$706.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chlorella segment is readjusted to a revised 4.9% CAGR for the next 8-year period. The U.S. Market is Estimated at $299.9 Million, While China is Forecast to Grow at 6.8% CAGR The Microalgae market in the U.S. is estimated at US$299.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$331.5 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 5.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR. What`s New for 2023? Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession. Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to digital archives and Research Platform Complimentary updates for one year Key Topics Covered: MARKET OVERVIEW Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) Urgency of Ensuring Sustainability & Robust Investments in Algal Biotechnology as a Means to Achieve the Goal Provides the Foundation for Growth Sustainability Becomes More Important than Ever. Here's Why The Time to Get Our Act Together & Move Towards a Circular Bioeconomy Has Come Sustainable Investments to Emerge Into an Unstoppable Force in the Coming Decade Interest Deepens in Algal Biotechnology as a Potent Tool for Establishing a Circular Bioeconomy After Years of Neglect, The Current Focus on Sustainability is Bringing Algae Biotechnology Back Into the Spotlight Microalgae: A Quick Primer Recent Market Activity Innovations World Brands MARKET TRENDS & DRIVERS Robust Outlook for Nutraceuticals Strengthened by Pandemic Induced Focus on Immunity Drives Opportunities for Algae as Supplements and Nutritional/Functional Food Sources Nutraceuticals Market Outlook Increasing Familiarity With & Confidence in Nutraceuticals Primes the Market for Acceptance of Algae Based Food & Supplements Marine Nutraceuticals in the Spotlight Expanding Population, Rising Food Security & Increasing Consumption of Meat Drive Popularity of Microalgae as Feed Ingredients for Livestock Production Rise in Animal Meat Production Drives Demand for Feed Fortification by Algae Among Livestock Farmers Ban on Use of Antibiotics Drives Demand for Microalgal-Based Feed Increasing Animal Feed Sources with Algae: A Review Growing Popularity of Non-Animal Based Protein Bodes Well for the Rise of Algae Proteins Rising Carbon Footprint of Animal Agriculture Leads to Shift in Consumer Preference for Non-Animal Based Protein Alternatives A Growing Market for Protein Alternatives Expands the Addressable Market Opportunity for Algae Proteins Microalgae in the Food Industry is Poised for Healthy Growth Microalgae Emerges Into the Spotlight as the Biofuel of the Future Biodiesel Outlook in the Wake of Decarburization Efforts Robust Growth Projected for Biodiesel Brightens the Outlook for Algae Biofuel: Global Market for Biofuel (In US$ Billion) for Years 2020, 2022, 2024 & 2026 Growing Consensus that the Widely Adopted Biofuel Strategy to Reduce Vehicle Emission in Reality Is a Mistake, Drives Interest in Algae Biofuel Algae Based Biofuel Storms into a Spotlight With the Promise of Remedying the Situation Algae Based Inks Emerges as the Future of Inks Here's What is Going on the Field of Algae Based Inks Strong Demand for Eco-Friendly Ink from the Packaging Industry Bodes Well for Growth in this Segment Algae Cosmetics Promises to Slice Through the Lucrative Cosmetics Industry Supported by the Trend Towards Natural Ingredients Consumers Switching to Natural & Organic Cosmetics Lead Manufacturers to Explore the Potential of Using Algae in Cosmetics Algae's Role the Future of the Global Beauty Industry: A Review Robust Demand for Pharmaceutical Drugs Expands Algae & Microalgae Applications in Drug Formulations More Drugs Being Manufactured Means More Opportunities for the Use of Algae in Medicines & Drug Development Algae in Medicine: A Review FOCUS ON SELECT PLAYERS (Total 184 Featured) Algatechnologies Ltd. Allmicroalgae - Natural Products, SA Beijing Gingko Group Bluetec Naturals Co., Ltd C.B.N.Bioengineering Co., Ltd. Cyanotech Corporation DIC Corporation DSM N.V. E.I.D. - Parry (India) Limited Earthrise Nutritionals LLC Fuji Chemical Industries Co., Ltd. Fuqing King Dnarmsa Spirulina Co., Ltd. Jiangshan Comp Spirulina Co., Ltd. Naturex S.A Novozymes A/S NOW Health Group, Inc. Phycom Taiwan Chlorella Manufacturing Company Yunnan Green A Biological Project Co., Ltd. Zhejiang Binmei Biotechnology Co.,Ltd. For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets

Chugai Pharmaceutical Co., Ltd., Tokyo and Fuji Chemical Industries Co., Ltd., Toyama announced that two companies entered into a business transfer agreement recently for Ulcerlmin® (generic name, sucralfate hydrate) for the treatment of gastritis/peptic ulcer manufactured and marketed by Chugai. Ulcerlmin, created and developed by Chugai, has been launched in Japan since 1968. Currently, the drug is approved in more than 30 countries and has contributed to treatment for many patients in Japan and other countries. Based on the agreement, the rights related to supply of drug substances to overseas manufacturing and sales companies of Ulcerlmin and the rights related to the marketing authorization of the drug in Japan, will be devolved to Fuji Chemical Industries from Chugai on April 1, 2019 and by September 30, 2019, respectively. For Japanese market, after the succession of the Ulcerlmin business, distribution of the products manufactured by Chugai will continue for a certain period to ensure stable supply of the drug. The products will be gradually switched to those manufactured by Fuji Chemical Industries along with fading of Chugai’s products from the market. The new sales and marketing scheme in Japan will be announced by Fuji Chemical Industries at a later date. For overseas markets, Fuji Chemical Industries will be responsible for supply of drug substances, while manufacturing and sales companies in each country will continue to distribute the product. Chugai will corporate with Fuji Chemical Industries to achieve a successful succession so that they can continuously implement activities to ensure stable supply, provide product information which meets medical needs, and promote the appropriate use of Ulcerlmin. Effects of the agreement on consolidated results of operations of Chugai for the business term ending in December 2019 are expected to be slight.